Regeneron's antibody platform as a durable edge
The case was made that Regeneron's proprietary VelocImmune mouse platform gives it a best-in-class antibody development capability, leading to superior drugs, which is a key competitive advantage not easily replicated.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.